Félix Ratjen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 22 papers. Top paper: “Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI”.

Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.10.003

N/A

4.1DataRank · unranked

125 citations

Phuong T. Vu, M. Skalland, Lucas R. Hoffman, Christopher E. Pope, Daniel Gelfond +16 more

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00434-9

N/A

3.9DataRank · unranked

127 citations

Félix Ratjen, Renee Russell, Scott H. Donaldson, Kristin A. Riekert, Gregory S. Sawicki +91 more

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.05.011

N/A

0.520DataRank · unranked

31 citations

Silke van Koningsbruggen‐Rietschel, David P. Nichols, Donald R. VanDevanter, Jane C. Davies, T. Lee +20 more

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6- to 11-Year-Olds with Cystic Fibrosis: An Observational Study

Annals of the American Thoracic Society(2025)10.1513/annalsats.202501-103oc

N/A

0.374DataRank · unranked

10 citations

Sarah J. Morgan, Morgan McCreary, Phuong T. Vu, Peter Jorth, Sonya L. Heltshe +8 more

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification

Human Genetics and Genomics Advances(2022)10.1016/j.xhgg.2022.100156

N/A

0.330DataRank · unranked

8 citations

Angela Chen, Jiafen Gong, Lin Fan, Bhooma Thiruvahindrapuram, Wilson W. L. Sung +31 more

The future of cystic fibrosis: A global perspective

Pediatric Pulmonology(2025)10.1002/ppul.27337

N/A

0.208DataRank · unranked

3 citations

Félix Ratjen

High Quality Phasing Using Linked-Read Whole Genome Sequencing of Patient Cohorts Informs Genetic Understanding of Complex Traits

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.28.486092

N/A

0DataRank · unranked

1 citations

Angela Chen, Jiafen Gong, Lin Fan, Bhooma Thiruvahindrapuram, Wilson W. L. Sung +31 more

Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.05.010

N/A

0DataRank · unranked

41 citations

Umer Khan, John Clancy, Scott H. Donaldson, Scott D. Sagel, Steven M. Rowe +2 more

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00297-7

N/A

0DataRank · unranked

33 citations

John P. Clancy, Raksha Jain, Scott H. Donaldson, Isabelle Fajac, Christopher H. Goss +21 more

Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.05.013

N/A

0DataRank · unranked

22 citations

Qianting Lv, Eleni‐Rosalina Andrinopoulou, Leticia Gallardo-Estrella, Jean‐Paul Charbonnier, Daan Caudri +8 more

Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT

Journal of Clinical Medicine(2023)10.3390/jcm12072704

N/A

0DataRank · unranked

16 citations

Giuseppe A. Latino, Andrew J. White, Félix Ratjen, Jamie McDonald, Kevin J. Whitehead +6 more

Same‐Day Repeatability and 28‐Day Reproducibility of Xenon MRI Ventilation in Children With Cystic Fibrosis in a Multi‐Site Trial

Journal of Magnetic Resonance Imaging(2024)10.1002/jmri.29605

N/A

0DataRank · unranked

17 citations

David J. Roach, Joseph W. Plummer, Matthew M. Willmering, Brandon Zanette, Giles Santyr +9 more

Brain and lung arteriovenous malformation rescreening practices for children and adults with hereditary hemorrhagic telangiectasia

Orphanet Journal of Rare Diseases(2024)10.1186/s13023-024-03402-8

N/A

0DataRank · unranked

1 citations

Helen Kim, Steven W. Hetts, Félix Ratjen, Marianne S. Clancy, James R. Gossage +2 more

Brain AVM compactness score in children with hereditary hemorrhagic telangiectasia

Child s Nervous System(2024)10.1007/s00381-024-06366-z

N/A

0DataRank · unranked

0 citations

Arastoo Vossough, Helen Kim, Jeffrey Nelson, Michael T. Lawton, Jeffrey Pollak +26 more

Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.11.016

N/A

0DataRank · unranked

8 citations

Phuong T. Vu, Sonya L. Heltshe, George M. Solomon, Andrea Kelly, Jessica E. Pittman +3 more

Structural and Functional Pulmonary MRI to Predict Pulmonary Exacerbations in Cystic Fibrosis

CHEST Journal(2025)10.1016/j.chest.2025.10.041

N/A

0DataRank · unranked

0 citations

Abdullah S Bdaiwi, Matthew M. Willmering, Mark DiFrancesco, Zackary I. Cleveland, Giles Santyr +5 more

A cystic fibrosis lung disease modifier locus harbors tandem repeats associated with gene expression

medRxiv(2022)10.1101/2022.03.28.22272580

N/A

0DataRank · unranked

0 citations

Scott Mastromatteo, Cheng Wang, Jiafen Gong, Bhooma Thiruvahindrapuram, Wilson W. L. Sung +19 more

Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety

UNC Libraries(2020)10.17615/rvrz-qs52

N/A

0DataRank · unranked

2 citations

Félix Ratjen, Stephanie D. Davis, Carol Barlow, Stephen H. Daniel, R. S. Johnson +5 more

INHALED HYPERTONIC SALINE IN INFANTS AND CHILDREN LESS THAN SIX YEARS OF AGE WITH CYSTIC FIBROSIS: THE ISIS RANDOMIZED TRIAL

UNC Libraries(2020)10.17615/j6yw-jt32

N/A

0DataRank · unranked

0 citations

Margaret Rosenfeld, for the ISIS Study Group, Sharon McNamara, Stephen H. Daniel, Ron Rowbotham +5 more

Novel Outcome Measures for Clinical Trials in Cystic Fibrosis

UNC Libraries(2020)10.17615/p5jt-gn54

N/A

0DataRank · unranked

0 citations

José G. Venegas, Harm A.W.M. Tiddens, Michael Puderbach, Scott H. Donaldson, Steven M. Rowe +5 more

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study

American Journal of Respiratory and Critical Care Medicine(2022)10.1164/rccm.202202-0392oc

N/A

0DataRank · unranked

141 citations

Rossa Brugha, Silvia Gärtner, Julian Legg, Alexander Mœller, Pedro Mondéjar-López +19 more

Quantification metrics for telangiectasia using optical coherence tomography

Scientific Reports(2022)10.1038/s41598-022-05272-1

N/A

0DataRank · unranked

1 citations

Joel Ramjist, Chaoliang Chen, Weisong Shi, Nhu Nguyen, Tiffany Yeretsian +28 more